Conflict of interest statement: None.182. Eur J Med Chem. 2018 Jul 15;155:503-515. doi: 10.1016/j.ejmech.2018.06.026. Epub 2018 Jun 11.Novel pyrimidinic selenourea induces DNA damage, cell cycle arrest, and apoptosisin human breast carcinoma.Barbosa FAR(1), Siminski T(2), Canto RFS(3), Almeida GM(2), Mota NSRS(2), OuriqueF(2), Pedrosa RC(4), Braga AL(5).Author information: (1)Laboratório de Síntese de Substâncias de Selênio Bioativas (LabSelen),Departamento de Química, Universidade Federal de Santa Catarina (UFSC),Florianópolis, SC, Brazil.(2)Laboratório de Bioquímica Experimental (LABIOEX), Departamento de Bioquímica, Universidade Federal de Santa Catarina (UFSC), Florianópolis, SC, Brazil.(3)Laboratório de Química Medicinal de Compostos de Selênio (QMCSe), Programa de pós-graduação em Ciências da Saúde, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.(4)Laboratório de Bioquímica Experimental (LABIOEX), Departamento de Bioquímica, Universidade Federal de Santa Catarina (UFSC), Florianópolis, SC, Brazil.Electronic address: rozangela.pedrosa@ufsc.br.(5)Laboratório de Síntese de Substâncias de Selênio Bioativas (LabSelen),Departamento de Química, Universidade Federal de Santa Catarina (UFSC),Florianópolis, SC, Brazil. Electronic address: braga.antonio@ufsc.br.Novel pyrimidinic selenoureas were synthesized and evaluated against tumour andnormal cell lines. Among these, the compound named 3j initially showed relevantcytotoxicity and selectivity for tumour cells. Three analogues of 3j weredesigned and synthesized keeping in view the structural requirements of thiscompound. Almost all the tested compounds displayed considerable cytotoxicity.However, 8a, one of the 3j analogues, was shown to be highly selective andcytotoxic, especially for breast carcinoma cells (MCF-7) (IC50 = 3.9 μM).Furthermore, 8a caused DNA damage, inhibited cell proliferation, was able toarrest cell cycle in S phase, and induced cell death by apoptosis in human breastcarcinoma cells. Moreover, predictions of pharmacokinetic properties showed that 8a may present good absorption and permeation characteristics for oraladministration. Overall, the current study established 8a as a potential drugprototype to be employed as a DNA interactive cytotoxic agent for the treatmentof breast cancer.Copyright © 2018 Elsevier Masson SAS. All rights reserved.DOI: 10.1016/j.ejmech.2018.06.026 PMID: 29908443 